Potential Strategies for Clinical Translation of Repeated Cell Therapy

Despite encouraging preclinical findings, clinical trials of repeated cell therapy are relatively scarce. As a result, the potential of this treatment paradigm remains to be assessed. We propose that a carefully planned clinical trial design using repeated cell dosing could lead to significant progress in the field of cell therapy.